Clinical and microbiological study of enduracidin in infections due to methicillin-resistant strains of Staphylococcus aureus.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000097:blood / Q000494:pharmacology*; D001770:Blood Bactericidal Activity; D005260:Female; D006801:Humans; D008297:Male; D008712:Methicillin; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy; D010403:Penicillin Resistance; D010455:Peptides / Q000097:blood / Q000494:pharmacology; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D010455:Peptides; D008712:Methicillin